CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Comparative Study of metformin and pioglitazone in polycystic ovary syndrome

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 50
Year: 2019
COI code: DTOGIMED03_014
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Comparative Study of metformin and pioglitazone in polycystic ovary syndrome

  Nasrin Jalilian - Professor of Obstetrics and Gynecology, Gynecologist, Kermanshah University of Medical Sciences, Kermanshah, Iran
Maryam Zangeneh - Associate Professor of Obstetrics and Gynecology, Gynecologist, Kermanshah University ofMedical Sciences, Kermanshah, Iran
  Maryam Hematti - MSC of Statistics, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract:

Corresponding Author: Dr Nasrin Jalilian. Professor of Obstetrics and Gynecology, Gynecologist,Kermanshah University of Medical Sciences, Kermanshah, IranEmail:njalilian@yahoo.com Tell:09181311664Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders inwomen. PCOS comprises a broad spectrum of anomalies, including hyperandrogenism, chronicanovulation, obesity, and infertility. Insulin resistance and its compensatory hyperinsulinemia playa key role in the pathogenicity of PCOS. This study compares the effects of 2 types of insulinsensitizer drugs, metformin and pioglitazone, on clinical, metabolic, and endocrine characteristicsof women with PCOS.Methods: In this randomized clinical trial, 56 women with PCOS (ages 20–49 years) were treatedorally with either metformin (500 mg 3 times daily) or pioglitazone (30 mg daily) for 3 months.Clinical (body weight, blood pressure [BP], and body mass index) and laboratory indices (fastingblood sugar [FBS], serum triglyceride [TG], cholesterol, low‑density lipoprotein, high‑densitylipoprotein, insulin, testosterone, and dehydroepiandrosterone [DHEA]) were measured beforeand after therapy. Data were analyzed by Chi‑square and McNemar’s tests.Results: Significant decreases were seen after treatment with metformin in extent of hair loss (P =0.008),wrist circle (P = 0.011), weight (P = 0.047), diastolic BP (P = 0.023), and DHEA (P = 0.035). Asignificant decrease in TG was seen with pioglitazone treatment (P = 0.047). In both groups,significant decreases in acne, menstrual disturbance, FBS, and serum insulinwere seen.Conclusion: There is a significant amelioration of endocrine and metabolic indices with pioglitazonein PCOS patients. Although we were not able to recommend one treatment regime over the other,pioglitazone offers a useful, alternate treatment in women with PCOS who are not able to toleratemetformin.

Keywords:

Insulin resistance, metformin, pioglitazone, polycystic ovary syndrome

Perma Link

https://www.civilica.com/Paper-DTOGIMED03-DTOGIMED03_014.html
COI code: DTOGIMED03_014

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Jalilian, Nasrin; Maryam Zangeneh & Maryam Hematti, 2019, Comparative Study of metformin and pioglitazone in polycystic ovary syndrome, 3rd debatable topics on obstetrics gynecology & infertility, تهران, دانشگاه علوم پزشكي و خدمات بهداشتي و درماني شهيد بهشتي, https://www.civilica.com/Paper-DTOGIMED03-DTOGIMED03_014.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Jalilian, Nasrin; Maryam Zangeneh & Maryam Hematti, 2019)
Second and more: (Jalilian; Zangeneh & Hematti, 2019)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 1332
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.